4.7 Article

An optimized culture medium to isolate Lactobacillus fermentum strains from the human intestinal tract

期刊

FOOD & FUNCTION
卷 12, 期 15, 页码 6740-6754

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1fo00209k

关键词

-

资金

  1. National Natural Science Foundation of China Program [31871773, 31820103010, U1903205]
  2. Key Scientific and Technological Research Projects in the Key Areas of the Xinjiang Production and Construction Corps [2018AB010]
  3. National First-Class Discipline Program of Food Science and Technology [JUFSTR20180102]
  4. BBSRC Newton Fund Joint Centre Award
  5. Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province

向作者/读者索取更多资源

Research has shown the presence of Lactobacillus fermentum in the human gut and the potential health benefits it offers. A new optimized culture medium called LFMATA has been developed to isolate L. fermentum strains from human fecal samples more efficiently, leading to a 10-fold increase in the isolation rate compared to the previous medium LAMVAB. Genotype and phenotype analysis revealed insights into antibiotic resistance and carbohydrate metabolism in Lactobacillus strains.
Research studies have shown that Lactobacillus fermentum generally exists in the human gut and has potential health benefits on host health due to its antimicrobial and antioxidant properties. However, the lack of an effective culture medium for the isolation of L. fermentum has presented a significant obstacle on the path to screen L. fermentum strains from the human intestinal tract with a large diversity of commensal microbes. In this study, a total of 51 Lactobacillus species are detected in 200 human fecal samples and we aim to distinguish L. fermentum from these common existing Lactobacillus species and design a more efficient culture medium for isolating L. fermentum strains from the human gut. Based on antibiotic susceptibility and sugar utilization tests, a new optimized medium called LFMATA containing arabinose as the carbon source and 20 mg L-1 vancomycin, 64 mg L-1 gentamicin and 256 mg L-1 streptomycin was developed. Genotype and phenotype analysis for antibiotic resistance and carbohydrate metabolism showed that though glycometabolism-related genes (araA, xylA, manX, bglX, treP and rbsK) correlated with the carbon utilization of Lactobacillus, the genes conferring resistance to streptomycin (gidB and rpsL) and gentamicin (tlyA) were not directly associated with the antibiotic resistance of Lactobacillus strains. This new selective medium greatly increased the efficiency of screening L. fermentum strains from human fecal samples, with the rate of L. fermentum isolation on LFMATA being 10-fold higher than that on LAMVAB.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据